Britannia Life Sciences Inc's total assets for Q4 2024 were C$11.61M, a decrease of -47.62% from the previous quarter. TSE:BLAB total liabilities were C$5.31M for the fiscal quarter, a -67.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.